NCT05453786View on ClinicalTrials.gov

A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

June 23, 2022

Primary Completion Date

August 1, 2022

Study Completion Date

August 11, 2022

Conditions
Healthy Subjects
Interventions
DRUG

SID1903

Single oral administration of SID1903 after an overnight fast

DRUG

SID1903-R1/SID1903-R2

Single oral administration of SID1903-R1 and SID1903-R2 after an overnight fast

Trial Locations (1)

Unknown

Chungbuk National University Hospital, Cheongju-si

All Listed Sponsors
lead

SK Chemicals Co., Ltd.

INDUSTRY